Dr. Frits Van Rhee | CureTalks
Internationally known multiple myeloma researcher Frits van Rhee, M.D., Ph.D is a professor of medicine in the UAMS College of Medicine and director of Developmental and Translational Medicine in the Myeloma Institute. He joined the Myeloma Institute in 2001, establishing a laboratory for developing innovative medical treatments using the bodys immune system. He is the leader of multiple National Cancer Institute-funded grant projects related to developmental therapeutics and anti-myeloma effects of so-called natural killer cells in the bodys immune system. He earned his medical degree from the Erasmus University in Rotterdam, Netherlands in 1985 and is UK board certified in Internal Medicine and Hematology. van Rhee trained in Hematology and Bone Marrow Transplantation at the John Radcliffe University Hospital in Oxford and the Royal Postgraduate Medical School in London and earned his doctorate degree from the Imperial College of Science, Medicine and Technology at the University of London. He came to the U.S. in 1996 as a Fogarty Fellow under John Barrett, M.D. with the Allotransplant Section of the National Heart, Lung and Blood Institute at the National Institutes of Health.
Related Talks
Nonsecretory Multiple Myeloma: New Options in Assessment and Treatment
Hallmark of most multiple myeloma cases is the persistent production of some form of immunoglobulins, a phenomenon that brings the disease to attention.…
Will Modern Therapies Replace Auto and Allo Transplants in Myeloma Treatment?
In just the past 2 months, 3 new drugs for myeloma treatment have been approved by the FDA. In addition to this, there…
Total Therapy and Myeloma with UAMS
Total Therapy is the only program in the world which talk about a cure for myeloma. Total Therapy is based on the approach…